Ma Juning is a clinician-scientist specializing in neurosurgery with a strong focus on nanomedicine and targeted therapies for neurological disorders. His research centers on engineering biomimetic nanoparticles and cell membrane-coated nanocarriers to improve drug delivery across complex biological barriers, particularly in glioma, stroke, and pituitary adenomas. He has led competitive projects funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation, highlighting his capacity for independent and innovative research. His international training, including a joint doctoral program at Yale University, has strengthened his expertise in translational neuroscience and advanced therapeutic strategies. Dr. Ma has contributed to high-impact publications in leading journals such as Biomaterials, Nano Letters, and Materials Today Bio, reflecting the significance of his work in tumor microenvironment targeting and immunotherapy. His interdisciplinary background integrates neurosurgery, nanotechnology, and stem cell research, aiming to develop clinically viable solutions for challenging brain diseases. In addition to research, he demonstrates leadership through active roles in academic and clinical communities. With a solid foundation in both basic science and clinical practice, he continues to advance precision medicine approaches for neurological disease treatment.
Citation Metrics (Scopus)
500
400
300
200
50
30
10
0
Citations
h-index
i10-index
Featured Publications